- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Hospitals May Be Unfairly Penalized for Unpreventable Venous Thromboembolism
A study attempting to characterize the true preventability of venous thromboembolism determined that financial penalties based on the total number of patients who suffer blood clots in the lung or leg may be unfairly imposed.
A study attempting to characterize the true preventability of venous thromboembolism (VTE) determined that financial penalties based on the total number of patients who suffer blood clots in the lung or leg may be unfairly imposed.
Researchers with Johns Hopkins University School of Medicine reviewed 128 medical case histories and came to the conclusion that the current pay-for-performance system is a problem. Elliott R. Haut, MD, PhD, an associate professor of surgery at the Johns Hopkins University School of Medicine, explained that even when hospitals do everything they can to prevent VTE, they can still be penalized for patients who develop blood clots.
Nearly half of VTE events identified by the Maryland state program were not truly preventable, he said.
“We know we’re not going to get the VTE rate to zero, but my goal is to have every single one of these events—when they happen—occur when the patient receives best-practice, defect-free care,” Dr Haut said in a statement.
If the findings hold true across the state of Maryland and the rest of the country, hospitals may be penalized millions of dollars through inappropriate fines.
In a research letter published in JAMA Surgery, Dr Haut and his colleagues noted that even with the use of blood thinners and other best practices, some patients will still develop clots. Meanwhile, government regulatory agencies and health insurers are increasingly tracking the number of patients who develop blood clots and imposing financial penalties.
The researchers argue that instead of looking solely at total numbers of patients who develop clots, a better measure would be to track whether patients at risk for clots were appropriately prescribed and given clot-preventing medications.
“To reduce preventable harm, policymakers need to re-evaluate how they penalize hospitals and improve the measures they use to assess VTE prevention performance,” Dr Haut said. “In addition, clinicians need to ensure that patients receive all prescribed preventive therapies.”
Specialty Drug Costs Drive Medicare Part D Dermatology Expenditures
July 22nd 2025The rapidly increasing prescriptions for expensive specialty medications, rather than their price growth, are the primary driver of escalating dermatology Medicare Part D expenditures, necessitating policies that balance innovation, access, and affordability.
Read More
Primary Care Doctors Lead Rising Physician Exodus From Medicare
July 21st 2025According to the American Medical Association, blame for the ongoing physician shortage may lie with overly burdensome administrative processes, an antiquated Medicare payment system, and lack of education for residents in primary care and psychiatry.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
AI Meets Medicare: Inside CMS’ WISeR Model With Sanjay Doddamani, MD, MBA
July 17th 2025Sanjay Doddamani, MD, MBA, a former senior advisor to the Center for Medicare and Medicaid Innovation, and internist and cardiologist by training, explains how the Wasteful and Inappropriate Service Reduction (WISeR) Model hopes to work, and addresses concerns about delays and denials from revamped prior authorization processes.
Read More
